| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $221.8M | +19.8% |
| Cost of Revenue | $156.9M | +13.2% |
| Gross Profit | $64.9M | +39.4% |
| R&D Expense | $2.5M | +35.9% |
| SG&A Expense | $59.3M | +25.5% |
| Operating Income | $3.0M | +218.6% |
| Interest Expense | $9.9M | +193.4% |
| Pre-tax Income | -$3.7M | +64.8% |
| Income Tax | $49K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.6M | -18.7% |
| Accounts Receivable | $31.0M | +4.9% |
| Inventory | $58.2M | +12.8% |
| Current Assets | $111.2M | +2.5% |
| Total Assets | $195.4M | -3.0% |
| Current Liabilities | $48.5M | -11.5% |
| Long-term Debt | $44.6M | -14.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.2M | +151.1% |
| Investing Cash Flow | -$1.2M | +96.5% |
| Financing Cash Flow | -$5.1M | -112.5% |
| -98.5% |
| Net Income | -$3.7M | +72.9% |
| EPS (Basic) | -$0.07 | +69.6% |
| EPS (Diluted) | -$0.07 | +69.6% |
| Total Liabilities |
| $115.0M |
| -3.9% |
| Stockholders' Equity | $51.9M | -2.6% |